Our study showed that human recombinant FGF4 (rFGF4) improved maternal glucose tolerance in high fat diet (HFD) induced gestational diabetes mice, and decreased neural tube defects (NTDs) of embryos in both HFD induced and streptozotocin (STZ) induced gestational diabetes mice. Here, FGF4 is linked to gestational diabetes.